NanoVibronix, Inc. NAOV Cash Flow

Nanovibronix, inc. (NAOV)

CashFlow / Quarterly

Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14
Cash flows from operating activities:
Net loss
-1,193,000	-833,000	-1,089,000	-2,679,000	-1,197,000	-1,344,000	-824,000	-789,000	-1,641,000	-1,599,000	-848,000	-877,000	-1,120,000	-606,000	-610,000	-495,000	-781,000	-1,039,000	-434,000	-630,000	-800,000	-766,000	-578,000	-503,000
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation
-	-	-	-	-	1,000	1,000	2,000	-1,000	1,000	4,000	1,000	1,000	2,000	2,000	2,000	2,000	2,000	3,000	2,000	3,000	3,000	1,000	2,000
Stock-based compensation
199,000	110,000	111,000	1,335,000	223,000	498,000	59,000	109,000	117,000	147,000	185,000	351,000	224,000	163,000	56,000	65,000	67,000	72,000	71,000	10,000	10,000	4,000	7,000	3,000
Noncash interest expense
-	0	3,000	7,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of derivative liabilities
-	0	-107,000	5,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Warrant modification expense
-	0	0	-412,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Discount amortization of promissory notes
-	-	-	-	-	0	0	0	332,000	545,000	315,000	5,000	-	-	-	-	-	-	-	-	-	-	-	-75,000
Benefit component of Promissory Notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	-99,000	-285,000	-	-	-	-
Revaluation of warrants to purchase Common stock
-	-	-	-	-	0	0	0	256,000	424,000	-166,000	35,000	192,000	44,000	146,000	1,000	310,000	688,000	-11,000	-25,000	-	-	-	-
Changes in operating assets and liabilities:
Trade receivable
-	-	-	-	-	-	-	-	-	-	-	-	-5,000	4,000	-4,000	6,000	-1,000	-8,000	-4,000	-3,000	-	-	-	-
Valuation of warrants to purchase Common stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-32,000
Trade receivable
-	-64,000	171,000	-27,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,000
Other accounts receivable and prepaid expenses
7,000	128,000	125,000	-87,000	-	-	-	-	-	-	-	-	-29,000	-52,000	69,000	-32,000	9,000	-21,000	441,000	-362,000	-66,000	22,000	12,000	-1,000
Inventory
-32,000	2,000	-39,000	46,000	-	-	-	-	-	-	-	-	4,000	4,000	-17,000	5,000	-3,000	21,000	24,000	-6,000	0	-28,000	-10,000	7,000
Increase in trade payables
-	-	-	-	-	-	-	-	-	-	-	-	13,000	41,000	-15,000	-15,000	-	-	-	-	-	-	-	15,000
Trade payables
-57,000	-157,000	113,000	37,000	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-50,000	-12,000	-	-	-	-
Other accounts payable
-	-236,000	201,000	-126,000	-	-	-	-	-	-	-	-	149,000	45,000	3,000	47,000	8,000	5,000	239,000	-357,000	-69,000	181,000	76,000	-5,000
Changes in operating assets and liabilities
-	-	-	-	-	-	-	-189,000	-	-	-	78,000	-	-	-	-	-	-	-	-	-	-	-	-
Accrued severance pay, net
-	0	-39,000	4,000	-	15,000	8,000	0	-5,000	0	7,000	2,000	-	-	-	-	-	-	-	-	-	-	-	-
Increase in accrued severance pay, net
-	-	-	-	-	-	-	-	-	-	-	-	90,000	0	-12,000	12,000	0	0	0	-1,000	-	-	-	-
Net cash used in investment activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,000	-7,000	0	0	-1,000	0	-	-	-	-
Decrease in accrued severance pay, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Accrued interest on Promissory Notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	231,000
Net cash used in operating activities
-1,032,000	-1,113,000	-792,000	-937,000	-881,000	-798,000	-1,004,000	-867,000	-780,000	-483,000	-514,000	-405,000	-	-	-	-	-	-	-	-	-	-	-	-157,000
Cash flows from investing activities:
Accrued interest on Promissory Notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	7,000	58,000	-	-	-	-
Net cash used in operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-478,000	-362,000	-380,000	-264,000	-537,000	-299,000	-	-	-	-
Purchases of property plant and equipment
-	-	-	-	0	3,000	3,000	2,000	-	0	2,000	0	0	0	1,000	7,000	0	0	1,000	0	-	-	-	-
Net cash used in investing activities
-	-	-	-	0	-3,000	-3,000	-2,000	-	0	-2,000	0	-	-	-	-	-	-	-	-	-	-	-	-
Cash flows from financing activities:
Proceeds from issuance of Convertible Promissory Note and warrants
-	-	-	225,000	-	0	0	0	0	350,000	680,000	350,000	-	-	-	0	0	0	0	3,005,000	-	-	0	0
Proceeds from exercise of options
-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	33,000	0	0	0	0	-	-	-	-
Net cash provided by financing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	33,000	0	0	0	3,005,000	-	-	-	-
Proceeds from issuance of Promissory Notes and warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	100,000
Net cash provided by financing activities
112,000	1,000,000	2,979,000	225,000	50,000	13,000	31,000	0	5,056,000	350,000	680,000	350,000	-	-	-	-	-	-	-	-	-	-	-	100,000
Net increase in cash and cash equivalents
-920,000	-113,000	2,187,000	-712,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Increase (decrease) in cash and cash equivalents
-	-	-	-	-	-788,000	-976,000	-869,000	4,278,000	-133,000	164,000	-55,000	-426,000	-267,000	-479,000	-336,000	-380,000	-264,000	-538,000	2,706,000	52,000	-68,000	69,000	-57,000
Discount on convertible notes
0	0	189,000	225,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-105,000	55,000	-13,000	149,000
Conversion of Promissory Notes into Preferred B-1, B-2 stock and Preferred C stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	1,609,000	3,457,000	0	0	0	0